Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Nuclear Medicine

Free Subscription Articles published in Nuklearmedizin Retrieve available abstracts of 90 articles: HTML format

Single Articles

June 2026
1. BUDDENKOTTE T, Apostolova II, Opfer R, Klutmann S, et al
   On the utility of ChatGPT in conducting a literature review on deep learning for dopamine transporter SPECT with [(1)(2)(3)I]ioflupane.
   Nuklearmedizin. 2026 Jun 24. doi: 10.1055/a-2890-8325.
   PubMed     Abstract available
   
   
   
2. LIAO T, Fu G, Long Y, Li L, et al
   McCune-Albright Syndrome with Extensive Fibrous Dysplasia Evaluated by 18F-FDG PET/CT and Whole-body Bone Scintigraphy: A Case Report.
   Nuklearmedizin. 2026 Jun 24. doi: 10.1055/a-2843-4797.
   PubMed    
   
   
   
3. BALTACIOGLU MH
   False-Positive Rib Lesion on Bone Scintigraphy and 68Ga-PSMA PET/CT: Fibrous Dysplasia Mimicking Metastasis.
   Nuklearmedizin. 2026 Jun 24. doi: 10.1055/a-2843-4897.
   PubMed    
   
   
   
4. TATOGLU MT, Uslu H
   [68Ga]Ga-FAPI-04 PET/CT Delineates Peritoneal Carcinomatosis in Invasive Lobular Breast Cancer with Limited FDG Avidity.
   Nuklearmedizin. 2026 Jun 11. doi: 10.1055/a-2883-7848.
   PubMed    
   
   
   
5. BUCHERT R, Meyer PT, Albert NL, Barthel H, et al
   German Society of Nuclear Medicine procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals (09/2025).
   Nuklearmedizin. 2026 Jun 2. doi: 10.1055/a-2821-9573.
   PubMed     Abstract available
   
   
   
6. BARTHEL H, Brendel M, Albert N, Boecker H, et al
   Updated Procedure Guideline of the German Society of Nuclear Medicine for Amyloid Brain PET Imaging 3.0.
   Nuklearmedizin. 2026;65:223-235.
   PubMed     Abstract available
   
   
   
7. TATOGLU MT, Okten IN, Ibisoglu E, Soylemez Akkurt T, et al
   Baseline FDG PET/CT-Defined Axillary Burden Predicts Axillary Pathologic Complete Response After Neoadjuvant Therapy in Breast Cancer.
   Nuklearmedizin. 2026;65:207-216.
   PubMed     Abstract available
   
   
   
8. SIEGMUND SC, Serfling SE, Higuchi T, Buck A, et al
   Emerging Theranostic Targets in Squamous Cell Carcinoma of the Head and Neck.
   Nuklearmedizin. 2026;65:217-222.
   PubMed     Abstract available
   
   
   May 2026
9. KARASKIWIECZ E, Syka A, Mottaghy FM, Lutje S, et al
   Late post-treatment 131I SPECT/CT reveals additional lymph node metastasis of papillary thyroid carcinoma.
   Nuklearmedizin. 2026 May 6. doi: 10.1055/a-2852-9891.
   PubMed    
   
   
   April 2026
10. LEONTEV A, Lokhova A, Khalimon A, Khodzhibekova M, et al
    Impact assessment of [18F]FDG PET/CT in predicting EGFR gene mutation status in patients with lung adenocarcinoma using recovery coefficient-based correction of semi-quantitative and volume-based PET metrics.
    Nuklearmedizin. 2026 Apr 13. doi: 10.1055/a-2777-2278.
    PubMed     Abstract available
    
    
    
11. ROGASCH JMM, Amthauer H, Kluge R, Bares R, et al
    DGN procedural guideline for bone scintigraphy with SPECT and SPECT/CT in children and adolescents.
    Nuklearmedizin. 2026 Apr 10. doi: 10.1055/a-2784-7659.
    PubMed     Abstract available
    
    
    
12. SUN TT, Zhu LB, Jiang L, Liu ET, et al
    [18F]FDG PET/CT diagnosis and follow-up of arterial intimal sarcoma of the left atrium.
    Nuklearmedizin. 2026;65:93-96.
    PubMed    
    
    
    
13. APOSTOLOVA II, Buddenkotte T, Jedid L, Klutmann S, et al
    Difficult-to-interpret dopamine transporter SPECT with [123I]ioflupane in the diagnosis of parkinsonism.
    Nuklearmedizin. 2026;65:83-92.
    PubMed     Abstract available
    
    
    
14. LINDNER O, Goetz C, Bengel FM, Linke A, et al
    Nuclear cardiology - Current status of the clinical application.
    Nuklearmedizin. 2026;65:52-59.
    PubMed     Abstract available
    
    
    February 2026
15. FREESMEYER M, Kuhnel C, Voigt E, Schmidt TN, et al
    Radioiodine Therapy Unit as a "No-Care" Ward - A First Experience Report.
    Nuklearmedizin. 2026;65:22-29.
    PubMed     Abstract available
    
    
    December 2025
16. MONSEF A, Saboktakin F, Sadeghi F, Elhaie M, et al
    Experimental approach for optimizing dose regimen of 68Ga-DOTATATE PET/CT for neuroendocrine tumor (NET) imaging in current high sensitivity scanners: Phantom and Patient Study.
    Nuklearmedizin. 2025;64:341-351.
    PubMed     Abstract available
    
    
    
17. KRATZER W, Steinkellner S, Skotnik D, Peters L, et al
    Diagnosis of hepatic alveolar echinococcosis:18F-FDG-PET activity compared to the Echinococcus multilocularis Ulm Ultrasound Classification.
    Nuklearmedizin. 2025 Dec 1. doi: 10.1055/a-2744-4139.
    PubMed     Abstract available
    
    
    November 2025
18. LINDNER O, Gutberlet M, Burchert W, Derlin T, et al
    Myocardial Perfusion SPECT 2024 in Germany: Results of the 10th Survey.
    Nuklearmedizin. 2025 Nov 24. doi: 10.1055/a-2738-2589.
    PubMed     Abstract available
    
    
    October 2025
19. VOLTIN CA, Kottlors J, Borchmann P, Godel P, et al
    Performance of a large language model in lymphoma stage assignment based on written PET/CT reports.
    Nuklearmedizin. 2025 Oct 14. doi: 10.1055/a-2707-4584.
    PubMed    
    
    
    
20. KALANTARI F, Rendl G, Hecht S, Pirich C, et al
    Atypical local laryngeal cancer recurrence mimicking thyroid uptake on 18F-FDG PET/CT.
    Nuklearmedizin. 2025;64:316-317.
    PubMed    
    
    
    
21. MANDIC A, Kraljevic I, Skoric Polovina T, Zibar Tomsic K, et al
    Diagnostic Performance of 99 mTc-Sestamibi SPECT/CT and 18F-Choline PET/CT in Locating Hyperfunctioning Parathyroid Glands in Patients with Primary Hyperparathyroidism.
    Nuklearmedizin. 2025;64:308-312.
    PubMed     Abstract available
    
    
    
22. AMBULKAR KS, Shah R, Lila A, Sharma A, et al
    Outcomes of 68Ga-NODAGA-Exendin-4 PET/CT Guided Surgical Management of Insulinomas in MEN1: A Preliminary Study.
    Nuklearmedizin. 2025;64:301-307.
    PubMed     Abstract available
    
    
    
23. MIKSCH J, Yousefzadeh-Nowshahr E, Hardiansyah D, Glatting G, et al
    First clinical application of silicon-based [(1)(8)F]siPSMA-14 in prostate cancer patients: A proof-of-concept study.
    Nuklearmedizin. 2025;64:285-293.
    PubMed     Abstract available
    
    
    September 2025
24. CHIKASUE T, Kurata S, Edamitsu S, Koganemaru M, et al
    Central Conducting Lymphatic Abnormalities in Noonan Syndrome Identified Using SPECT/CT Lymphoscintigraphy.
    Nuklearmedizin. 2025 Sep 30. doi: 10.1055/a-2695-8007.
    PubMed    
    
    
    August 2025
25. OKUDAN B, Atalay M, Hakkoymaz ZR, Seven B, et al
    Diagnostic value of presurgical 68Ga-PSMA-11 PET/CT in prostate cancer patients with different ISUP grade groups.
    Nuklearmedizin. 2025 Aug 22. doi: 10.1055/a-2665-8087.
    PubMed     Abstract available
    
    
    
26. JOZANOVIC V, Lukic D, Brataljenovic M, Huic D, et al
    Diagnostic challenge in parathyroid imaging: incidental schwannoma mimicking primary hyperparathyroidism on 18F-fluorocholine PET/CT.
    Nuklearmedizin. 2025 Aug 22. doi: 10.1055/a-2655-5291.
    PubMed    
    
    
    
27. TATOGLU MT, Alan Selcuk N, Erincik K
    Benign bone lesions mimicking metastasis on 68Ga-FAPI PET/CT.
    Nuklearmedizin. 2025;64:277-280.
    PubMed    
    
    
    
28. GAMMEL MCM, Hansen K, Weber W, Rauscher I, et al
    From Metastases to Splenosis: Resolving SSR PET Pitfalls with Tc-99m-Labeled Denatured Red Blood Cell Scintigraphy.
    Nuklearmedizin. 2025;64:272-273.
    PubMed    
    
    
    June 2025
29. LIU S, Pan Q, Xu H, Luo Y, et al
    Activation of fibroblast in intestinal Behcet's disease shown by 68Ga-FAPI-04 PET/CT.
    Nuklearmedizin. 2025;64:231-233.
    PubMed    
    
    
    
30. YANG H, Zhang Y, Guan Z, Li C, et al
    The diagnostic performance of an [18F]FDG PET/CT algorithm for preoperative evaluation of extrahepatic cholangiocarcinoma: a retrospective study.
    Nuklearmedizin. 2025;64:205-214.
    PubMed     Abstract available
    
    
    
31. DROPMANN JA, Kleespies A, Fuerst H, Kremer M, et al
    Importance of oxyphil cells for 99mTc-sestamibi uptake in primary hyperparathyroidism: a retrospective observational study.
    Nuklearmedizin. 2025;64:215-224.
    PubMed     Abstract available
    
    
    May 2025
32. WENDLER T, Rogasch JMM, Bastian MB, Burchert W, et al
    Correction: Digitalization of Nuclear Medicine in Germany - Status Quo 2024.
    Nuklearmedizin. 2025 May 20. doi: 10.1055/a-2604-5823.
    PubMed    
    
    
    
33. BAEHR M, Dietrich I, Liepe K
    [99mTc]Tc-PSMA SPECT/CT is a promising tool in the staging of renal cell carcinoma.
    Nuklearmedizin. 2025 May 12. doi: 10.1055/a-2578-7222.
    PubMed    
    
    
    April 2025
34. BUCHERT R, Drzezga A, Schreckenberger M, Langen KJ, et al
    The Status of Neuroimaging with SPECT and PET in Germany: Results from the 1st Survey on Nuclear Neuroimaging in Germany in 2023.
    Nuklearmedizin. 2025 Apr 15. doi: 10.1055/a-2566-1487.
    PubMed     Abstract available
    
    
    
35. LUNA R, Laheru DA, Shin EJ, Lossos C, et al
    Pancreatic Neuroendocrine Tumor incidentally found on 68Ga-PSMA PET/CT.
    Nuklearmedizin. 2025;64:177-179.
    PubMed    
    
    
    
36. WENDLER T, Rogasch JMM, Bastian MB, Burchert W, et al
    Digitalization of Nuclear Medicine in Germany - Status Quo 2024.
    Nuklearmedizin. 2025;64:156-162.
    PubMed     Abstract available
    
    
    
37. ORBOM A, Evans-Axelsson S, Jansson B, Vilhelmsson Timmermand O, et al
    Intratumoral distribution and pharmacokinetics of the radiolabeled ICAM-1 targeting monoclonal antibody R6.5 in a prostate cancer mouse model.
    Nuklearmedizin. 2025;64:163-169.
    PubMed     Abstract available
    
    
    
38. EBRAHIMIFARD A, Rajabi H, Geramifar P, Luster M, et al
    The impact of the xSPECT reconstruction algorithms on the recovery coefficients value for small tumors: a phantom study with 177Lu.
    Nuklearmedizin. 2025;64:132-140.
    PubMed     Abstract available
    
    
    
39. VOGT JK, Vogt WK, Heinzel A, Mottaghy FM, et al
    Comparison of 2D and 3D lung lobe quantification with Ventilation/Perfusion Ratio.
    Nuklearmedizin. 2025;64:142-149.
    PubMed     Abstract available
    
    
    March 2025
40. BAUDE JK, Mottaghy FM, Derlin T, Fischer A, et al
    PSMA - Targeted Clinical Molecular Imaging of Atherosclerosis: Correlation with Cardiovascular Risk Factors.
    Nuklearmedizin. 2025;64:13-21.
    PubMed     Abstract available
    
    
    January 2025
41. VURAL TOPUZ O, Bagbudar S, Aksu A, Soylemez Akkurt T, et al
    Radiomic signatures derived from baseline 18F FDG PET/CT imaging can predict tumor-infiltrating lymphocyte values in patients with primary breast cancer.
    Nuklearmedizin. 2025 Jan 28. doi: 10.1055/a-2512-8212.
    PubMed     Abstract available
    
    
    December 2024
42. CEGLA P, Currie G, Wroblewska JP, Kazmierska J, et al
    [18F]FDG PET/CT Imaging and Hematological Parameters Can Help Predict HPV Status in Head and Neck Cancer.
    Nuklearmedizin. 2024 Dec 4. doi: 10.1055/a-2365-7808.
    PubMed     Abstract available
    
    
    
43. GRUNERT M, Schenke SA, Konrad A, Schutze C, et al
    Thyroid scintigraphy: establishing a clinically useful normal range for 99mTc pertechnetate uptake.
    Nuklearmedizin. 2024;63:337-346.
    PubMed     Abstract available
    
    
    November 2024
44. RUGGIERO C, Maracaja D, Rowe SP
    Langerhans Cell Histiocytosis-Associated Vertebra Plana on FDG PET.
    Nuklearmedizin. 2024 Nov 27. doi: 10.1055/a-2438-7469.
    PubMed    
    
    
    
45. ZHAO G, Huang Z
    A Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor on 18F-FDG PET/CT.
    Nuklearmedizin. 2024 Nov 20. doi: 10.1055/a-2383-2527.
    PubMed     Abstract available
    
    
    
46. SCHULZ L, Funk GC, Kirchbacher K, Egger E, et al
    Comparison of whole-body 18F-FDG-PET/CT with 18F-FDG-PET/CT limited to skull base to upper abdomen for primary staging of lung cancer - a retrospective explorative analysis.
    Nuklearmedizin. 2024 Nov 11. doi: 10.1055/a-2438-7278.
    PubMed     Abstract available
    
    
    October 2024
47. VOLTIN CA, Spreckelmeyer S, Essler M, Holzgreve A, et al
    Toward the future of nuclear medicine: How young professionals are getting involved and what plans they have.
    Nuklearmedizin. 2024;63:284-286.
    PubMed    
    
    
    
48. VOGEL J, Haghghi S, Herkula C, Petersen M, et al
    Interobserver Agreement of visual and semi-quantitative methods in 99mTc-Methoxy-Isobuty-Isonitrile (MIBI) imaging for risk stratification of hypofunctional thyroid nodules.
    Nuklearmedizin. 2024;63:294-299.
    PubMed     Abstract available
    
    
    
49. ZEIDLER R, Tiepolt S, Hesse S, Sabri O, et al
    Superimposing kidneys in [99mTc]MAG-3 and [99mTc]DMSA-scintigraphy in a tricky case of an extensive, displacing growing retroperitoneal liposarcoma.
    Nuklearmedizin. 2024;63:306-307.
    PubMed    
    
    
    September 2024
50. JAFARI E, Manafi-Farid R, Ahmadzadehfar H, Salek F, et al
    Prognostic Significance of Baseline Clinical and [68Ga]Ga-PSMA PET Derived Parameters on Biochemical Response, Overall Survival, and PSA Progression-Free Survival in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Undergoing [177Lu]Lu
    Nuklearmedizin. 2024 Sep 3. doi: 10.1055/a-2365-8113.
    PubMed     Abstract available
    
    
    August 2024
51. RAHBAR NIKOUKAR L, Seifert R, Ventura D, Schindler P, et al
    Prognostic value of pretherapeutic 68Ga-PSMA-11-PET based imaging parameters in mCRPC patients treated with PSMA radioligands.
    Nuklearmedizin. 2024 Aug 29. doi: 10.1055/a-2383-2468.
    PubMed     Abstract available
    
    
    
52. VOGT JK, Vogt WK, Heinzel A, Mottaghy FM, et al
    Computational Decision Support for PE Diagnosis based on Ventilation Perfusion Ratio.
    Nuklearmedizin. 2024;63:259-266.
    PubMed     Abstract available
    
    
    July 2024
53. LANDAU F, Hermann S, Schelhaas S, Schafers M, et al
    18F-labelled gentiobiose as potential PET-radiotracer for specific bacterial imaging: precursor synthesis, radiolabelling and in vitro evaluation.
    Nuklearmedizin. 2024 Jul 31. doi: 10.1055/a-2365-8054.
    PubMed     Abstract available
    
    
    
54. BREDENSTEINER L, Ventura D, Rassek P, Schafers M, et al
    Determination of the optimal imaging protocol for [18F]PSMA-PET-CT for the detection of bone metastases in prostate cancer patients.
    Nuklearmedizin. 2024 Jul 12. doi: 10.1055/a-2344-6825.
    PubMed     Abstract available
    
    
    May 2024
55. SCHMIDT M, Hohberg M, Felcht M, Kuhn T, et al
    [Nuclear medicine procedure guideline for sentinel lymph node localization].
    Nuklearmedizin. 2024 May 24. doi: 10.1055/a-2319-8306.
    PubMed     Abstract available
    
    
    
56. HEIDEMANNS S, Trautmann S, Weidt D, Hellwig D, et al
    Update of the competence-based catalog of learning objectives in nuclear medicine for the study of human medicine in Germany.
    Nuklearmedizin. 2024 May 22. doi: 10.1055/a-2319-7549.
    PubMed     Abstract available
    
    
    April 2024
57. WIELENBERG CF, Fostitsch JC, Volz C, Marks R, et al
    FDG-PET/CT is a powerful tool to predict and evaluate response to chimeric antigen receptor (CAR) T-cell therapy in Non-Hodgkin-Lymphoma (NHL).
    Nuklearmedizin. 2024 Apr 9. doi: 10.1055/a-2283-8417.
    PubMed     Abstract available
    
    
    
58. BOCK F, Frerker B, Schubert L, Rennau H, et al
    Impact of 68Ga-PSMA PET/CT on radiation treatment planning of prostate cancer patients.
    Nuklearmedizin. 2024 Apr 5. doi: 10.1055/a-2284-0593.
    PubMed     Abstract available
    
    
    
59. SAEED S, Dimopoulos I, Begum N, Kroger JR, et al
    [Not Available].
    Nuklearmedizin. 2024;63:78-80.
    PubMed    
    
    
    
60. WERNER R, Haug A, Buske C, Heidegger S, et al
    CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges.
    Nuklearmedizin. 2024;63:57-61.
    PubMed     Abstract available
    
    
    March 2024
61. GACULA SIG, Kunte SC, Unterrainer LM, Rubenthaler J, et al
    Correction: Divergent growth on [18F]FDG PET/CT in a case of co-existing pulmonary metastatic leiomyosarcoma and papillary thyroid carcinoma.
    Nuklearmedizin. 2024 Mar 25. doi: 10.1055/a-2286-9571.
    PubMed    
    
    
    
62. USLU H, Sahin D, Tatoglu MT, Ibisoglu E, et al
    Growing Teratoma Syndrome Revealed By F-18 FDG PET/CT.
    Nuklearmedizin. 2024 Mar 14. doi: 10.1055/a-2273-2350.
    PubMed    
    
    
    
63. GACULA SIG, Kunte SC, Unterrainer LM, Rubenthaler J, et al
    Divergent growth on [18F]FDG PET/CT in a case of co-existing pulmonary metastatic leiomyosarcoma and papillary thyroid carcinoma.
    Nuklearmedizin. 2024 Mar 11. doi: 10.1055/a-2273-2447.
    PubMed    
    
    
    
64. LIU Y, Tang W, Huang Z
    Correction: 99mTc-MDP Bone Scan and 18F-FDG PET/CT Imaging of Primary Hepatic Osteosarcoma.
    Nuklearmedizin. 2024 Mar 4. doi: 10.1055/a-2275-1035.
    PubMed    
    
    
    February 2024
65. CHEN M, Liu Y
    Correction: 18F-FDG PET/CT images of adult pulmonary blastoma: a case report.
    Nuklearmedizin. 2024 Feb 20. doi: 10.1055/a-2265-4049.
    PubMed    
    
    
    
66. AYDAR S, Knobl H, Burchert W, Lindner O, et al
    Diagnostic accuracy of artificial intelligence-enabled vectorcardiography versus myocardial perfusion SPECT in patients with suspected or known coronary heart disease.
    Nuklearmedizin. 2024 Feb 20. doi: 10.1055/a-2263-2322.
    PubMed     Abstract available
    
    
    
67. CHEN M, Liu Y
    18F-FDG PET/CT images of adult pulmonary blastoma: a case report.
    Nuklearmedizin. 2024 Feb 7. doi: 10.1055/a-2237-8775.
    PubMed    
    
    
    
68. UMUTLU L, Nensa F, Demircioglu A, Antoch G, et al
    Radiomics Analysis of Multiparametric PET/MRI for N- and M-Staging in Patients with Primary Cervical Cancer.
    Nuklearmedizin. 2024;63:34-42.
    PubMed     Abstract available
    
    
    
69. FISCHER M, Schneider-Eicke J
    Nonosseous bone seeking tracer focal uptake in the conventional scintigraphy.
    Nuklearmedizin. 2024;63:45-47.
    PubMed    
    
    
    
70. DIETLEIN M, Grunwald F, Schmidt M, Kreissl MC, et al
    [Guideline for Radioiodine Therapy for Benign Thyroid Diseases (6/2022 - AWMF No. 031-003)].
    Nuklearmedizin. 2024;63:8-20.
    PubMed     Abstract available
    
    
    January 2024
71. FREUDENBERG R, Kastner D, Kotzerke J, Brogsitter C, et al
    [Evaluation of risk analysis in treatment with unsealed radioactive substances in nuclear medicine].
    Nuklearmedizin. 2024 Jan 23. doi: 10.1055/a-2237-8639.
    PubMed    
    
    
    
72. MAMAN A
    Incidental Papillary Thyroid Carcinoma Detected by Ga-68 DOTATATE PET/CT: A Rare Case Study and Clinical Considerations.
    Nuklearmedizin. 2024 Jan 23. doi: 10.1055/a-2238-4186.
    PubMed    
    
    
    
73. NOURBAKHSH S, Salehi Y, Farzanehfar S, Ghaletaki R, et al
    FAPI PET/CT provides higher uptake and better target to back ground in recurrent and metastatic tumors of patients with Iodine refractory papillary thyroid cancer compared with FDG PET CT.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2185-7746.
    PubMed     Abstract available
    
    
    
74. ARSLANTAS E, Aycicek A, Esen Akkas B, Tahtakesen Gucer TN, et al
    The Role of FDG- PET/CT in Detecting Bone Marrow Involvement in Childhood Solid Tumors.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2224-9441.
    PubMed     Abstract available
    
    
    
75. VURAL TOPUZ O, Bagbudar S
    Cervical Cancer Metastasis to the Stomach Masquerading as Primary Gastric Cancer: A Case Report of a Rare Metastasis Detected via 18F-FDG PET/CT.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2224-9673.
    PubMed    
    
    
    
76. SANTO G, Di Santo G, Zelger B, Virgolini I, et al
    Incidental Finding of a Pancreatic Adenocarcinoma on [68Ga]Ga-PSMA-11 PET/CT in a mCRPC patient under [177Lu]Lu-PSMA-617 Radioligand Therapy.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2221-3220.
    PubMed    
    
    
    December 2023
77. SERFLING SE, Buck A, Rowe SP, Higuchi T, et al
    Red Bull PET/CT.
    Nuklearmedizin. 2023 Dec 22. doi: 10.1055/a-2195-0138.
    PubMed     Abstract available
    
    
    
78. ROGASCH JMM, Shi K, Kersting D, Seifert R, et al
    Methodological evaluation of original articles on radiomics and machine learning for outcome prediction based on positron emission tomography (PET).
    Nuklearmedizin. 2023;62:361-369.
    PubMed     Abstract available
    
    
    
79. WENDLER T, Kreissl MC, Schemmer B, Rogasch JMM, et al
    Artificial Intelligence-powered automatic volume calculation in medical images - available tools, performance and challenges for nuclear medicine.
    Nuklearmedizin. 2023;62:343-353.
    PubMed     Abstract available
    
    
    
80. HELLWIG D, Hellwig NC, Boehner S, Fuchs T, et al
    Artificial Intelligence and Deep Learning for Advancing PET Image Reconstruction: State-of-the-Art and Future Directions.
    Nuklearmedizin. 2023;62:334-342.
    PubMed     Abstract available
    
    
    
81. MIEDERER I, Rogasch JMM, Wendler T
    AI in Nuclear Medicine - a review of the current situation.
    Nuklearmedizin. 2023;62:332-333.
    PubMed    
    
    
    November 2023
82. LOHMANN P, Bundschuh RA, Miederer I, Mottaghy FM, et al
    Clinical Applications of Radiomics in Nuclear Medicine.
    Nuklearmedizin. 2023 Nov 7. doi: 10.1055/a-2191-3271.
    PubMed     Abstract available
    
    
    October 2023
83. FUCHS T, Kaiser L, Muller D, Papp L, et al
    Enhancing Interoperability and Harmonisation of Nuclear Medicine Image Data and Associated Clinical Data.
    Nuklearmedizin. 2023 Oct 31. doi: 10.1055/a-2187-5701.
    PubMed     Abstract available
    
    
    
84. RASSEK P, Bobe S, Kies P, Roll W, et al
    The value of core needle biopsy in the diagnostic workup of a [18F]FDG-PET positive thyroid metastasis from colorectal cancer.
    Nuklearmedizin. 2023 Oct 23. doi: 10.1055/a-2178-6908.
    PubMed    
    
    
    
85. BROSCH-LENZ JF, Delker A, Schmidt F, Tran-Gia J, et al
    On the Use of Artificial Intelligence for Dosimetry of Radiopharmaceutical Therapies.
    Nuklearmedizin. 2023 Oct 12. doi: 10.1055/a-2179-6872.
    PubMed     Abstract available
    
    
    
86. MOON H, Ku EJ, Kim C
    Ectopic Thyroid Tissue in the Uterus Identified by Iodine-131 SPECT/CT.
    Nuklearmedizin. 2023;62:294-295.
    PubMed    
    
    
    
87. KUSTNER T, Hepp T, Seith F
    Multiparametric Oncologic Hybrid Imaging: Machine Learning Challenges and Opportunities.
    Nuklearmedizin. 2023;62:306-313.
    PubMed     Abstract available
    
    
    September 2023
88. DEININGER K, Raacke JN, Yousefzadeh-Nowshahr E, Kropf-Sanchen C, et al
    Combined morphologic-metabolic biomarkers from [18F]FDG-PET/CT stratify prognostic groups in low-risk NSCLC.
    Nuklearmedizin. 2023 Sep 11. doi: 10.1055/a-2150-4130.
    PubMed     Abstract available
    
    
    
89. MIEDERER I, Rogasch JMM, Fischer R, Fuchs T, et al
    The Medical Informatics Initiative and the Network University Medicine - Perspectives for Nuclear Medicine.
    Nuklearmedizin. 2023 Sep 8. doi: 10.1055/a-2067-7642.
    PubMed     Abstract available
    
    
    August 2023
90. FROHLICH M, Schmalzing M, Buck A, Bley TA, et al
    PET-Derived Increased Inflammation in Large Vessels is linked to Relapse-Free Survival in Patients with Giant Cell Arteritis.
    Nuklearmedizin. 2023;62:229-234.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum